Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
- 31 August 2000
- journal article
- Published by Elsevier BV in Drug Resistance Updates
- Vol. 3 (4), 247-255
- https://doi.org/10.1054/drup.2000.0152
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Production of a TEM-24 Plasmid-Mediated Extended-Spectrum β-Lactamase by a Clinical Isolate of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 2000
- Interplay between the Efflux Pump and the Outer Membrane Permeability Barrier in Fluorescent Dye Accumulation in Pseudomonas aeruginosaBiochemical and Biophysical Research Communications, 1999
- Are we approaching the end of the antibiotic era?Current Opinion in Microbiology, 1998
- Cationic peptides: a new source of antibioticsTrends in Biotechnology, 1998
- Fluoroquinolones in the treatment of cystic fibrosis: A critical appraisalEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Treatment of Pseudomonas lung infection in cystic fibrosis with piperacillin plus tobramycin versus ceftazidime monotherapy: Preliminary communicationPediatric Pulmonology, 1989
- Drug disposition in cystic fibrosisThe Pediatric Infectious Disease Journal, 1987
- Antibiotic Pharmacokinetics in Cystic FibrosisClinical Pharmacokinetics, 1987
- Disposition of tobramycin in patients with cystic fibrosis: A prospective controlled studyThe Journal of Pediatrics, 1984
- THE PENETRATION OF ANTIBIOTICS THROUGH SODIUM ALGINATE AND THROUGH THE EXOPOLYSACCHARIDE OF A MUCOID STRAIN OF PSEUDOMONAS AERUGINOSAThe Lancet, 1981